Quantifying the expression of VEGF using qRT-PCR, evaluation of MVD and their correlation with clinicopathological factors in laryngeal squamous cell carcinoma

Yıl 2011, Cilt: 21 Sayı: 3, 137 - 144, 30.07.2011

Pelin Koçdor Işıl Çoker Ümit Bayol Deniz Altınel Duygu Ünüvar Purcu Suat Kaptaner Orhan Gazi Yiğitbaşı

Öz

Objectives: In this study we quantified the expression of vascular endothelial growth factor VEGF using quantitative real-time polymerase chain reaction in laryngeal squamous cell carcinoma LSCC tissues and evaluated the correlation between the level of VEGF and microvessel density MVD , and clinicopathological factors. Patients and Methods: Twenty-seven patients with LSCC undergoing total or partial laryngectomy at the Ear, Nose, and Throat and Head and Neck Surgery Department of the Izmir Tepecik Training and Research Hospital between September 2006 and July 2008. There was no VEGF expression in two patients that were excluded from the study. Twenty-five patients 24 males, 1 female; mean age 61 years; range 43 to 82 years were included in this study, but MVD levels of 10 patients could not be determined. Results: As defined by the 2003 American Joint Committee on Cancer AJCC TNM classification, seven patients 28% were stage 1, six patients 24% were stage 2, four patients 16% were stage 3, and eight patients 32% were stage 4. Thirteen patients 52% had well-differentiated G1 tumors, and twelve had moderately differentiated tumors. Among the 15 patients for whom the MVD was determined, the median value was 48, with a range 13-78; vessels / 3.76 mm2 . Among the 25 patients for whom the VEGF level was determined, the median value was 0.035 vessels / 3.76 mm2 range 0.010-0.127 . Conclusion: We could not find a statistical correlation between clinicopathological factors and either VEGF or MVD. Our study demonstrates that VEGF is expressed by LSCC.

Anahtar Kelimeler

Laryngeal squamous cell carcinoma, quantitative real-time polymerase chain reaction, vascular endothelial growth factor

Larengeal skuamöz hücreli karsinomalarda qRT-PCR kullanılarak VEBF ekspresyonu ölçümü, MDY değerlendirilmesi ve bunların klinikopatolojik faktörlerle ilişkisi

Öz

Amaç: Bu çalışmada, larenks skuamöz hücreli kanser LSHK dokularında kantitatif gerçek zamanlı polimeraz zincir reaksiyonu kullanılarak vasküler endotelyal büyüme faktörü VEBF düzeyleri ölçüldü, VEBF, mikrodamar yoğunluğu MDY ve klinikopatolojik faktörler arasındaki ilişki değerlendirildi.Hastalar ve Yöntemler: Eylül 2006 - Temmuz 2008 tarihleri arasında İzmir Tepecik Eğitim ve Araştırma Hastanesi Kulak Burun Boğaz Baş-Boyun Cerrahisi Kliniği’ne başvuran, 27 LSHK hastasına total veya parsiyel cerrahi uygulandı. Yirmi yedi hastanın ikisi, VEBF ekspresyonu olmadığı için çalışmaya dahil edilmedi. Çalışmaya 25 hasta 24 erkek, 1 kadın; ort. yaş 61 yıl; dağılım 43-82 yıl alındı, fakat bu hastaların 10’unda MDY seviyesi belirlenemedi.Bulgular: Amerikan Kanser Komitesi AJCC ’nin 2003 yılında tanımladığı TNM sınıflandırmasına göre; yedi hasta %28 evre 1, altı hasta %24 evre 2, dört hasta %16 evre 3, sekiz hasta %32 evre 4 idi. On üç hasta iyi derece diferansiye G1 , 12 hasta orta derece diferansiye G2 tümöre sahipti. Mikrodamar yoğunluk değerleri belirlenebilen 15 hasta içinde, median değer 48 idi dağılım 13-78; damar / 3.76 mm2 . Vasküler endotelyal büyüme faktörü seviyeleri tespit edilebilen 25 hasta arasında, median değer 0.035 damar / 3.76 mm2 dağılım 0.010-0.127 idi.Sonuç: Klinikopatolojik faktörler ve ayrıca VEBF ve MDY arasında istatistiksel olarak anlamlı bir ilişki bulunamadı. Bizim çalışmamız LSKH’den VEBF salındığını gösterdi

Anahtar Kelimeler

Larenks skuamöz hücreli kanser, kantitatif gerçek zamanlı polimeraz zincir reaksiyonu, vasküler endotelyal büyüme faktörü

Kaynakça

• Smith BD, Haffty BG. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat Oncol Investig 1999;7:125-44.
• Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001;23:147-59.
• Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005;41:683-93.
• Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000;12:229-39.
• Smith BD, Haffty BG, Sasaki CT. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance. Ann Otol Rhinol Laryngol 2001;110:221-8.
• Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2005;131:624-30.
• Yuan A, Yu CJ, Luh KT, Chen WJ, Lin FY, Kuo SH, et al. Quantification of VEGF mRNA expression in non- small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription- PCR. Lab Invest 2000;80:1671-80.
• Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999;5:775-82. 9. Kyzas PA, Stefanou D, Agnantis NJ. Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol 2004;40:941-7.
• Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, et al. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 2002;24:1004-11.
• Lentsch EJ, Goudy S, Sosnowski J, Major S, Bumpous JM. Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters. Laryngoscope 2006;116:397-400.